1. A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis. (26th February 2013) Authors: Mrowietz, U.; de Jong, E.M.G.J.; Kragballe, K.; Langley, R.; Nast, A.; Puig, L.; Reich, K.; Schmitt, J.; Warren, R.B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 4(2014:Apr.) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel mutation in IL36RN underpins childhood pustular dermatosis. (16th February 2015) Authors: Ellingford, J.M.; Black, G.C.M.; Clayton, T.H.; Judge, M.; Griffiths, C.E.M.; Warren, R.B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 2(2016:Feb.) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis. (1st December 2019) Authors: Yiu, Z.Z.N.; Mason, K.J.; Barker, J.N.W.N.; Hampton, P.J.; McElhone, K.; Smith, C.H.; Warren, R.B.; Griffiths, C.E.M.; Lunt, M.; Burden, A.D. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis. (2nd July 2019) Authors: Yiu, Z.Z.N.; Mason, K.J.; Barker, J.N.W.N.; Hampton, P.J.; McElhone, K.; Smith, C.H.; Warren, R.B.; Griffiths, C.E.M.; Lunt, M.; Burden, A.D. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A study of the drug tildrakizumab in psoriasis patients. (1st March 2020) Authors: Reich, K.; Warren, R.B.; Iversen, L.; Puig, L.; Pau‐Charles, I.; Igarashi, A.; Ohtsuki, M.; Falqués, M.; Harmut, M.; Rozzo, S.; Lebwohl, M.G.; Cantrell, W.; Blauvelt, A.; Thaçi, D. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A study of the drug tildrakizumab in psoriasis patients. (28th February 2020) Authors: Reich, K.; Warren, R.B.; Iversen, L.; Puig, L.; Pau‐Charles, I.; Igarashi, A.; Ohtsuki, M.; Falqués, M.; Harmut, M.; Rozzo, S.; Lebwohl, M.G.; Cantrell, W.; Blauvelt, A.; Thaçi, D. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64‐week multinational randomized phase IV study in 1790 patients (PSO‐TOP). (1st July 2017) Authors: Reich, K.; Zschocke, I.; Bachelez, H.; de Jong, E.M.G.J.; Gisondi, P.; Puig, L.; Warren, R.B.; Ortland, C.; Mrowietz, U. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64‐week multinational randomized phase IV study in 1790 patients (PSO‐TOP). (6th June 2017) Authors: Reich, K.; Zschocke, I.; Bachelez, H.; de Jong, E.M.G.J.; Gisondi, P.; Puig, L.; Warren, R.B.; Ortland, C.; Mrowietz, U. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB0727 Increased Rates of Hypertension in Patients with Psoriatic Arthritis Compared To Psoriasis Alone: Results from The UK Biobank. (15th July 2016) Authors: Bellou, E.; Verstappen, S.M.M.; Cook, M.; Sergeant, J.C.; Warren, R.B.; Barton, A.; Bowes, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0822 Therapeutic Response in Adalimumab-Treated Patients with Psoriatic Arthritis in Relation to Weight. (9th June 2015) Authors: Mease, P.; Gladman, D.D.; Ritchlin, C.T.; Warren, R.B.; Rubant, S.; Li, Y.; Dorr, A.P.; Anderson, J.K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗